Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous occlusion of the left atrial appendage: An expert consensus statement.
Klug D, Commeau P, Defaye P, Thambo JB, Gras D, Aubry P, Pasquie JL, Guerin P, Teiger E, Koning R, Piot O; Heart Rhythm, Pacing Group, the Atheroma, Interventional Cardiology Group of the French Society of Cardiology. Klug D, et al. Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):460-7. doi: 10.1016/j.acvd.2015.02.001. Arch Cardiovasc Dis. 2015. PMID: 26645055 Free article. Review.
Guidelines issued by the French Society of Cardiology concerning the competence, performance and environment required in the practice of diagnostic and interventional cardiac electrophysiology.
Piot O, Anselme F, Bovéda S, Chauvin M, Daubert JC, Defaye P, Deharo JC, Gras D, Hermida JS, Kacet S, Klug D, Leenhardt A, le Heuzey JY, Mabo P, Pisapia A, Sadoul N, Salvador-Mazenq M, Cazeau S; Cardiac Rhythm and Pacing Group; French Society of Cardiology. Piot O, et al. Among authors: klug d. Arch Cardiovasc Dis. 2011 Nov;104(11):586-90. doi: 10.1016/j.acvd.2011.09.002. Epub 2011 Nov 8. Arch Cardiovasc Dis. 2011. PMID: 22117911 Free article. No abstract available.
Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
Fauchier L, Marijon E, Defaye P, Piot O, Sadoul N, Perier MC, Gras D, Klug D, Algalarrondo V, Bordachar P, Deharo JC, Leclercq C, Babuty D, Boveda S; DAI-PP Investigators. Fauchier L, et al. Among authors: klug d. Am J Cardiol. 2015 May 15;115(10):1415-22. doi: 10.1016/j.amjcard.2015.02.031. Epub 2015 Feb 18. Am J Cardiol. 2015. PMID: 25784518
Safety, feasibility, and outcome results of cardiac resynchronization with triple-site ventricular stimulation compared to conventional cardiac resynchronization.
Anselme F, Bordachar P, Pasquié JL, Klug D, Leclercq C, Milhem A, Alonso C, Deharo JC, Gras D, Probst V, Piot O, Savouré A. Anselme F, et al. Among authors: klug d. Heart Rhythm. 2016 Jan;13(1):183-9. doi: 10.1016/j.hrthm.2015.08.036. Epub 2015 Sep 26. Heart Rhythm. 2016. PMID: 26325531 Free article. Clinical Trial.
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators. Marijon E, et al. Among authors: klug d. Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330420 Free PMC article.
Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
Ascoeta MS, Marijon E, Defaye P, Klug D, Beganton F, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Boveda S, Piot O; DAI-PP Investigators. Ascoeta MS, et al. Among authors: klug d. Heart Rhythm. 2016 May;13(5):1045-1051. doi: 10.1016/j.hrthm.2015.12.046. Epub 2016 Jan 1. Heart Rhythm. 2016. PMID: 26749313 Free article.
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.
Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S. Providência R, et al. Among authors: klug d. J Am Heart Assoc. 2016 Feb 12;5(2):e002756. doi: 10.1161/JAHA.115.002756. J Am Heart Assoc. 2016. PMID: 26873687 Free PMC article.
Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study.
Perrin T, Mechulan A, Boveda S, Beganton F, Defaye P, Sadoul N, Piot O, Klug D, Gras D, Perier MC, Algalarrondo V, Bordachar P, Babuty D, Fauchier L, Leclercq C, Marijon E, Deharo JC; DAI-PP Investigators. Perrin T, et al. Among authors: klug d. Int J Cardiol. 2016 Oct 15;221:951-6. doi: 10.1016/j.ijcard.2016.06.189. Epub 2016 Jun 30. Int J Cardiol. 2016. PMID: 27441474
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification.
Providência R, Boveda S, Defaye P, Segal O, Algalarrondo V, Sadoul N, Lambiase P, Piot O, Klug D, Perier MC, Bouzeman A, Barra S, Bories MC, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo JC, Leclercq C, Marijon E; DAI-PP Investigators. Providência R, et al. Among authors: klug d. Am J Cardiol. 2016 Oct 15;118(8):1225-1232. doi: 10.1016/j.amjcard.2016.07.037. Epub 2016 Jul 29. Am J Cardiol. 2016. PMID: 27561197
382 results